Fingerprint
Dive into the research topics of 'A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
Lauren Averett Byers, Alejandro Navarro, Eric Schaefer, Melissa Johnson, Mustafa Özgüroğlu, Ji Youn Han, Igor Bondarenko, Irfan Cicin, Konstantin H. Dragnev, Adam Abel, Xuejing Wang, Samuel McNeely, Scott Hynes, Aimee Bence Lin, Martin Forster
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations